On April 6, 2022, the Centers for Disease Control and Prevention (CDC) published a notice on the Federal Register soliciting nominations for membership on the agency’s Healthcare Infection Control Practices Advisory Committee (HICPAC) by September 17, 2022. HICPAC is seeking members that are experts in a range of health fields including, but not limited to, infectious diseases, internal medicine, epidemiology, health policy, public health, and related medical fields to provide guidance to the federal government on the development and evaluation of healthcare infection prevention and control guidelines; the development of policy statements regarding the prevention and surveillance of healthcare-associated infections and healthcare; and new and updated surveillance methodologies related to healthcare- associated infections. The National Council of Urban Indian Health (NCUIH) encourages nominations of Urban Indian organization leaders and members.
Read the Federal Register notice here.
Read more about HICPAC here.
Nominations for membership on the HICPAC must be submitted by September 17, 2022. All nominations should be mailed to HICPAC, Division of Healthcare Quality Promotion, NCEZID, CDC, 1600 Clifton Road NE, Mailstop H16-3, Atlanta, Georgia 30329-4027, emailed (recommended) to email@example.com, or faxed to (404) 639-4043. Candidates should submit a current curriculum vitae, including complete contact information (telephone numbers, mailing address, email address), and at least one letter of recommendation from person(s) not employed by the U.S. Department of Health and Human Services. Members may be invited to serve for four-year terms.
Please contact NCUIH policy if you would like assistance with submission or if you plan to apply.
HICPAC Objectives and Scope
HICPAC is a federal advisory committee appointed to provide advice and guidance to the Department of Health and Human Services and CDC regarding the practice of infection control and strategies for surveillance, prevention, and control of healthcare-associated infections, antimicrobial resistance, and related events in United States healthcare settings. The committee consists of 14 members knowledgeable in the fields of expertise including, but not limited to, infectious diseases, infection prevention, healthcare epidemiology, nursing, clinical and environmental microbiology, surgery, hospitalist medicine, internal medicine, epidemiology, health policy, health services research, public health, and related medical fields.